.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for an en...
.On the heels of a stage 3 succeed that stopped working to blow away financiers, Ironwood Pharmaceut...
.Do not cease Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball aft...
.Accept to today's Chutes & Ladders, our roundup of considerable leadership hirings, shootings an...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has returned to the resource of its own antipsychotic goliath Vraylar seeking one more runaw...
.GenSight Biologics is weeks far from losing loan. Again. The biotech only possesses enough cash to ...
.Monopar Rehabs is actually bouncing back a medicine coming from the dump of AstraZeneca's rare dise...
.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts ...
.After forming a genetics therapy partnership with Dyno Rehabs in 2020, Roche is back for even more....